These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15225143)

  • 61. Knockout of arsenic (+3 oxidation state) methyltransferase is associated with adverse metabolic phenotype in mice: the role of sex and arsenic exposure.
    Douillet C; Huang MC; Saunders RJ; Dover EN; Zhang C; Stýblo M
    Arch Toxicol; 2017 Jul; 91(7):2617-2627. PubMed ID: 27847981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome.
    Irawati D; Mamo JC; Dhaliwal SS; Soares MJ; Slivkoff-Clark KM; James AP
    Lipids Health Dis; 2016 Sep; 15(1):169. PubMed ID: 27686975
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.
    Reyes-Soffer G; Moon B; Hernandez-Ono A; Dionizovik-Dimanovski M; Jimenez J; Obunike J; Thomas T; Ngai C; Fontanez N; Donovan DS; Karmally W; Holleran S; Ramakrishnan R; Mittleman RS; Ginsberg HN
    Sci Transl Med; 2016 Jan; 8(323):323ra12. PubMed ID: 26819195
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans.
    Adiels M; Mardinoglu A; Taskinen MR; Borén J
    Front Physiol; 2015; 6():342. PubMed ID: 26635628
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of an isoenergetic traditional Mediterranean diet on apolipoprotein A-I kinetic in men with metabolic syndrome.
    Richard C; Couture P; Desroches S; Lichtenstein AH; Lamarche B
    Nutr J; 2013 Jun; 12(1):76. PubMed ID: 24499022
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Insulin-stimulated degradation of apolipoprotein B100: roles of class II phosphatidylinositol-3-kinase and autophagy.
    Andreo U; Guo L; Chirieac DV; Tuyama AC; Montenont E; Brodsky JL; Fisher EA
    PLoS One; 2013; 8(3):e57590. PubMed ID: 23516411
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome.
    Richard C; Couture P; Desroches S; Lichtenstein AH; Lamarche B
    J Lipid Res; 2013 Jan; 54(1):232-7. PubMed ID: 23125458
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nutritional systems biology modeling: from molecular mechanisms to physiology.
    de Graaf AA; Freidig AP; De Roos B; Jamshidi N; Heinemann M; Rullmann JA; Hall KD; Adiels M; van Ommen B
    PLoS Comput Biol; 2009 Nov; 5(11):e1000554. PubMed ID: 19956660
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with type 2 diabetes, impaired glucose metabolism and insulin levels.
    Rubin D; Helwig U; Pfeuffer M; Schreiber S; Boeing H; Fisher E; Pfeiffer A; Freitag-Wolf S; Foelsch UR; Doering F; Schrezenmeir J
    J Hum Genet; 2006; 51(6):567-574. PubMed ID: 16721486
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.
    Chan DC; Barrett PH; Watts GF
    Clin Biochem Rev; 2004 Feb; 25(1):31-48. PubMed ID: 18516204
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.
    Watts GF; Chan DC; Ooi EM; Nestel PJ; Beilin LJ; Barrett PH
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):877-82. PubMed ID: 16922825
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia.
    Chan DC; Barrett PH; Watts GF
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):369-85. PubMed ID: 24840265
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacological regulation of dyslipoproteinaemia in insulin resistant states.
    Chan DC; Watts GF
    Curr Vasc Pharmacol; 2008 Jan; 6(1):67-77. PubMed ID: 18220942
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods.
    Chan DC; Barrett PH; Watts GF
    Clin Sci (Lond); 2004 Sep; 107(3):233-49. PubMed ID: 15225143
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.